CDK7-IN-21

• UNSPSC Description:

  CDK7-IN-21 (compound A22) is a potent CDK7 inhibitor[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk7-in-21.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  C=C(F)C(NC(C=C1)=CC2=C1C(C(C=CC=C3)=C3CNC(N4N=C5)=NC(NC[C@@H]6[C@H](CNCC6)O)=NC4=C5C(C)C)=NC=C2)=O

• Molecular Weight:

  609.70

• References & Citations:

  [1]Kiyean NAM, et al. Compounds for degradation of cyclin-dependent kinase 7 (cdk7). Patent. WO2022248682A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2766124-39-2